Implant devices containing insulin-secreting ?-cells hold great promise for the treatment of diabetes. Using in vitro cell culture, long-term function and viability are enhanced when cultured with extracellular matrix (ECM) proteins. Here, our goal is to engineer a favorable environment within implant devices, where ECM proteins stably immobilized on polymer scaffolds, better support ?-cell adh...